REFERENCE BOOK
KDIGO Clinical Practice Guideline for Acute Kidney Injury
Research Recommendations
Research recommendation
-
We recommend further trials of ANP at doses below 0.1 µg/kg/min, for the prevention or treatment of AKI. There is a possibility that ANP might be effective if it is given at a lower dose (0.01–0.05 µg/kg/min) in patients prophylactically or with early AKI, and during a longer period than in previous large studies.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.